Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers The Lead Compound

Home › Targets › HER2/neu

HER2/neu (1 companies · 1 programs)

Companies with an active program directed at HER2/neu.

Greenwich LifeSciences, Inc. GLSI

GP2 — Breast Cancer Phase 3

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.